Paris, 18 May 2020: In an in-depth review of the market and having evaluated the collective developments from this year’s Pharmapack event, Gregor Anderson – MD of Pharmacentric Solutions – offers a positive appraisal of pharma’s drive towards sustainability.
“I am really encouraged by the massive strides we have made this year. As an industry, we are no longer paying lip service to sustainability and wherein once there might have just been a single dedicated employee, there are now entire teams looking at improving methods and exploring life-cycle impact” commented Anderson.
One of the big differences identified is the increased sharing across the industry and how actively involved the entire supply chain is in the discussion. Both the suppliers of packaging and devices are working more closely with big pharma and this is leading to accelerated development.
The next stage is interoperability, as for the industry to be able to truly meet sustainability goals it will need to stop applying bespoke solutions company by company. According to Anderson that means “bringing material suppliers into the debate and potentially working across the industry with big pharma, device and packaging suppliers together. So that we can deliver the economies of scale needed to incentivize the development of more environmentally sustainable materials. It’s a few years away yet, but standardised use of materials industry-wide could make a massive improvement to the options we have. And then, we need to extend this to how we are setting-up the networks to recycle these post use.”
Another big improvement is exploring how the patient reacts to new innovations and their behavior. For example, it has been overlooked in developments until recently, but reducing the misuse of medicines could be another massive stride forward. “It’s widely accepted that up to 50% of medicines don’t get used correctly by patients, ultimately leading to their waste or even unnecessary alternatives then being tried. Anything the industry can do to improve adherence will automatically be a very sustainable approach. But at the same time, we don’t want to be giving patients solutions that are too complex with large numbers of different devices and interfaces”, added Anderson.
The most encouraging aspect is that whilst no single solution will be the answer, there is active sharing across the industry, with even big pharma presenting data and case studies on how they have implemented improvements. To be fully sustainable, it’s going to take the industry to collaborate across a number of areas. “Overall, I am very encouraged by what I have seen this year. You only have to look at the number of dedicated sustainability presentations at Pharmapack and the number of new improvements present. I actually see a big role for Pharmapack in the future in providing the industry platforms to debate initiatives and share ideas”, concluded Anderson.
Pharmapack 2021 will be held at the Porte De Versailles in Paris (27-28 January, 2021) and is the leading hub for stakeholders across all parts of the pharmaceutical packaging and drug delivery supply chain, with over 5300 attendees and 400+ exhibitors from 75+ countries expected to be present.
“We cannot escape the wider issues of society at the moment, but I also think it’s important that we keep up momentum and continue to promote the great sustainability strides the industry has in the last year. In fact, it’s going to be a much bigger part of what are doing in the future at Pharmapack, in helping deliver platforms to coalesce new ideas around. We want the industry to see the event as a source of new debate, new analysis and new thinking – and we will publish a drug delivery and device summary paper later in the year,” commented Silvia Forroova, Brand Director at Pharmapack Europe.
The full podcast with Gregor Anderson on everything from replacing PVC in France to training doctors on devices, and the role the patient can be play in sustainability is available on CPhI’s new insights platform.
Notes to editors
Launched in 1997, Pharmapack is the European event for Pharmaceutical Packaging, Drug Delivery, Medical Devices and Machinery. Pharmapack started as a biennial conference and exhibition, taking place every other year in Paris, until industry developments demanded a more frequent event to help the industry stay up to date on the latest trends, developments and regulations. In the past 20+ years, the event has grown from a conference with a small table-top exhibition, to an event hosting 400+ exhibitors and welcoming 5,300 attendees over 2 days. In 2020, Pharmapack also featured the Match & Meet Programme (business matching), full 2-day Conference, 2-day Workshops, Learning Lab presentations, Awards ceremonies, a Start-up Hub, Innovation Gallery and Tours.
About Informa Markets
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.
For more information, please visit www.informamarkets.com.
The Informa Markets annual schedule of Pharmaceutical events include: CPhI Korea (26-28 August, 2020 at COEX – Seoul, Korea); CPhI North America (9 - 11 September, 2020 at Pennsylvania Convention Centre – Philadelphia, USA); CPhI Japan (30 September – 2 October, 2020 at Intex Osaka Exhibition Center – Osaka, Japan); CPhI, ICSE, P-MEC, FDF, InnoPack Worldwide, BioProduction (13-15 October, 2020 at Fiera Milano, Milan); CPhI South East Asia (4-6 November, 2020 at IMPACT Center – Bangkok, Thailand); CPhI & P-MEC India (25–27 November 2020 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India); CPhI and P-MEC China (16-18 December, 2020 at SNIEC – Shanghai, China); Pharmapack Europe (27-28 January 2021 at Paris Expo, Porte de Versailles – Paris, France); CPhI Middle East & Africa (24-25 March 2021).
For media enquiries, please contact:
Improving adherence to medication via smarter, patient-centric pharmaceutical packaging and extracting further value from existing medicines and delivery devices are two of the latest key strategies aimed at reducing waste and protecting the bottom line, according to experts at the recent Pharmapack Europe.
Pharmapack Europe has pinpointed a number of opportunities and threats that drug delivery and pharmaceutical packaging companies must address in 2020. In a year when the industry has begun exploring the full life cycle impact of medicines, the agenda will explore everything from a collaborative value chain approach to enabling plastic recycling.
Connectivity, customization and sustainability are driving pharmaceutical packaging and drug delivery innovation at Pharmapack Europe (#pharmapackeu), which opens in February 2020. The event is the leading exhibition dedicated to pharmaceutical packaging and drug delivery devices, with major industry players set to come together to discuss vital best practices, insights and strategies.
Switzerland overtakes Germany as Europe's biggest drug delivery innovator, with the UK and France close behind
As predicted by the ‘European drug delivery and packaging’ report earlier this year, new data shows innovation in drug delivery is accelerating across Europe. Ahead of Pharmapack Europe 2020 – the European event dedicated to drug packaging and delivery systems –, this research points to a continued acceleration of new device innovation and packaging solutions entering the market.
- Abdul Khalifeh
- Created 21 May 2020
- Modified 01 Jul 2020
- Hits 382